News

MONROE COUNTY, Pa. - Sanofi, maker of anti-inflammation drug Dupixent, will report third-quarter earnings Friday before the opening of U.S. markets. Paris-based Sanofi is the parent company of ...
POCONO TWP., Pa. - Sanofi Pasteur has gotten FDA approval for its new manufacturing facility in Monroe County. The move will allow the global pharmaceutical company to expand the production and ...
Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD).
France's Sanofi is the latest European pharma group to promise a big capital investment programme on manufacturing and R&D in the US, saying it intends to spend "at least $20 billion" there by the ...
See the latest Sanofi SA ADR stock price (SNY:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
Review the current valuation for Sanofi SA ADR (SNY:XNAS) stock based on a yearly calendar providing PE ratios, cash flow, EBITDA and other company valuation information.